These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16411308)

  • 1. [What happens when antiretroviral treatment is interrupted in clinical practice?].
    Marcos Sánchez F; Albo Castaño I; Joya Seijo D; del Valle Loarte P; Martín Barranco MJ
    An Med Interna; 2005 Oct; 22(10):502. PubMed ID: 16411308
    [No Abstract]   [Full Text] [Related]  

  • 2. 2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA Panel.
    Bucher HC; Wolbers M; Porter K
    JAMA; 2010 Nov; 304(17):1897; author reply 1897-8. PubMed ID: 21045094
    [No Abstract]   [Full Text] [Related]  

  • 3. Early versus deferred antiretroviral therapy for HIV.
    Hernán MA; Robins JM
    N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we be initiating antiretroviral therapy earlier? An argument in favour.
    Wood R
    S Afr Med J; 2005 Dec; 95(12):926, 928. PubMed ID: 16465350
    [No Abstract]   [Full Text] [Related]  

  • 5. Early versus deferred antiretroviral therapy for HIV.
    Buchbinder SP; Jain V
    N Engl J Med; 2009 Aug; 361(8):822; author reply 823-4. PubMed ID: 19692695
    [No Abstract]   [Full Text] [Related]  

  • 6. When to start antiretroviral therapy--ready when you are?
    Sax PE; Baden LR
    N Engl J Med; 2009 Apr; 360(18):1897-9. PubMed ID: 19339713
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring of antiretroviral therapy in low-resource settings.
    Bendavid E
    Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
    [No Abstract]   [Full Text] [Related]  

  • 8. Stopping antiretroviral therapy: role for therapeutic drug monitoring.
    Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P
    AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral therapy: when to start.
    Sellers CJ; Wohl DA
    Infect Dis Clin North Am; 2014 Sep; 28(3):403-20. PubMed ID: 25151563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV transmission from mother to child--HAART compared with dual therapy.
    Theron G; Nellensteijn M; Theron A; Louw J
    S Afr Med J; 2009 Oct; 99(10):717, 720. PubMed ID: 20128268
    [No Abstract]   [Full Text] [Related]  

  • 11. [Once-a-day highly active antiretroviral therapy. Present or future?].
    Pulido F; Hernando A
    Med Clin (Barc); 2003 Sep; 121(8):304-9. PubMed ID: 14499087
    [No Abstract]   [Full Text] [Related]  

  • 12. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When should children with HIV infection be started on antiretroviral therapy?
    Welch SB; Gibb D
    PLoS Med; 2008 Mar; 5(3):e73. PubMed ID: 18366251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of antiretroviral drugs during tuberculosis therapy.
    Kadhiravan T
    N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
    [No Abstract]   [Full Text] [Related]  

  • 15. If we can't get what we want, can we get what we need? optimizing use of antiretroviral therapy in the current era.
    Baker JV; Henry K
    Ann Intern Med; 2011 Apr; 154(8):563-5. PubMed ID: 21502654
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adults.
    González R; Castro P; García F; Plana M; Bayas JM; Lafuente S; Serrano B; Mora B; Argelich R; Gatell JM; Vilella A
    HIV Med; 2010 Sep; 11(8):535-9. PubMed ID: 20408890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antiretroviral drugs and approaches to HIV treatment.
    Paredes R; Clotet B
    AIDS; 2003; 17 Suppl 4():S85-96. PubMed ID: 15080184
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV survival benefit associated with earlier antiviral therapy.
    Mocroft A; Phillips AN; Lundgren JD
    Ann Intern Med; 2004 Apr; 140(7):578-9; author reply 579. PubMed ID: 15068990
    [No Abstract]   [Full Text] [Related]  

  • 19. Getting smarter--the toxicity of undertreated HIV infection.
    Currier JS; Baden LR
    N Engl J Med; 2006 Nov; 355(22):2359-61. PubMed ID: 17135590
    [No Abstract]   [Full Text] [Related]  

  • 20. [Optimal time for antiretroviral therapy of HIV infection: NA-ACCORD (North American AIDS cohort collaboration on research and design)].
    Jensen B; Nitschmann S; Häussinger D
    Internist (Berl); 2009 Dec; 50(12):1425-6. PubMed ID: 19902153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.